Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2025 FYStats 
Home
Equities
NMRA
Fundamentals

Neumora Therapeutics, Inc.

NMRA

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

0.00
0.000.00%
-

Assets

316.97M
▼-35.57M▼-10.09%
3 Months Change

Liabilities

29.91M
▼-1.89M▼-5.94%
3 Months Change

Free Cash Flow

-33.08M
▼-33.08M-∞%
-

Revenue/Cost Of Revenue

Loading...

Net Profit/Loss

Loading...

Assets/Liabilities

Loading...

Cash Flows

Loading...

Earnings Per Share

Loading...

Outstanding Shares

Loading...

Recent Quarterly and Annual Filings

2024-08-06
Form 10-Q
ID: 0000950170-24-091737
2024-08-06
Form 8-K
ID: 0000950170-24-091205
2024-06-14
Form 8-K
ID: 0001193125-24-161572
2024-05-07
Form 10-Q
ID: 0000950170-24-054448
2024-05-07
Form 8-K
ID: 0000950170-24-053933
2024-04-15
Form 8-K
ID: 0001193125-24-095472
2024-03-07
Form 8-K
ID: 0001193125-24-061473
2024-01-08
Form 8-K
ID: 0001193125-24-003968
2023-11-28
Form 8-K
ID: 0001193125-23-284303
2023-11-01
Form 10-Q
ID: 0000950170-23-057424